Literature DB >> 20935455

Oct1 is required for mTOR-induced G1 cell cycle arrest via the control of p27(Kip1) expression.

Mathieu Dalvai1, Karin Schubart, Arnaud Besson, Patrick Matthias.   

Abstract

Oct1 is a ubiquitously expressed transcription factor that is induced in response to DNA damage to modulate gene expression. Herein, Oct1 deficient mouse embryonic fibroblasts were used as a model to study the importance of Oct1 in cellular stress response. Cells lacking Oct1 kept proliferating and bypassed the G(1) cell cycle arrest induced by glucose or amino acid starvation. Indeed, mTOR-mediated regulation of proliferation was abolished in Oct1(-/-) cells starved for glucose or amino acids and Oct1(-/-) cells were also insensitive to mTOR inhibition by rapamycin. Furthermore, in wild-type cells, Oct1 controls the transcription of the CDK inhibitor p27(Kip1) downstream of the mTOR pathway and Oct1-null cells failed to upregulate p27(Kip1) in response to rapamycin or glucose starvation. p27(Kip1) is required for rapamycin or nutrient starvation-induced G(1)-arrest, as p27(-/-) fibroblasts were largely insensitive to rapamycin treatment or glucose starvation. Thus, Oct1 appears to be a critical mediator of the growth arrest induced by mTOR inhibition via the control of p27(Kip1) expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935455     DOI: 10.4161/cc.9.19.13154

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

Review 1.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

2.  Validation of p27KIP1 expression levels as a candidate predictive biomarker of response to rapalogs in patient-derived breast tumor xenografts.

Authors:  Xiao-Fei Ding; Dong-Qing Yin; Qian Chen; Hua-Yuan Zhang; Jun Zhou; Guang Chen
Journal:  Tumour Biol       Date:  2015-03-07

3.  The physiology and pathophysiology of rapamycin resistance: implications for cancer.

Authors:  Philip A Gruppuso; Joan M Boylan; Jennifer A Sanders
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

4.  Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation.

Authors:  Jinsuk Kang; Zuolian Shen; Jae-Min Lim; Hiroshi Handa; Lance Wells; Dean Tantin
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

5.  Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.

Authors:  Aparna Kaul; Yi-Hsien Chen; Ryan J Emnett; Sonika Dahiya; David H Gutmann
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

6.  p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy-lysosomal pathway and coordinate cell cycle and cell growth.

Authors:  Ada Nowosad; Pauline Jeannot; Caroline Callot; Justine Creff; Renaud Thierry Perchey; Carine Joffre; Patrice Codogno; Stephane Manenti; Arnaud Besson
Journal:  Nat Cell Biol       Date:  2020-08-17       Impact factor: 28.824

7.  p27 controls autophagic vesicle trafficking in glucose-deprived cells via the regulation of ATAT1-mediated microtubule acetylation.

Authors:  Ada Nowosad; Justine Creff; Pauline Jeannot; Raphael Culerrier; Patrice Codogno; Stephane Manenti; Laurent Nguyen; Arnaud Besson
Journal:  Cell Death Dis       Date:  2021-05-13       Impact factor: 8.469

8.  A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.

Authors:  Francesca Chiarini; Annalisa Lonetti; Gabriella Teti; Ester Orsini; Daniela Bressanin; Alessandra Cappellini; Francesca Ricci; Pier Luigi Tazzari; Andrea Ognibene; Mirella Falconi; Pasqualepaolo Pagliaro; Ilaria Iacobucci; Giovanni Martinelli; Sergio Amadori; James A McCubrey; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-12

Review 9.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

Review 10.  Advances in targeting signal transduction pathways.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Lin Sun; Nicole M Davis; Stephen L Abrams; Richard A Franklin; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli; Massimo Libra; Saverio Candido; Giovanni Ligresti; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Marco Donia; Ferdinando Nicoletti; Jerry Polesel; Renato Talamini; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Michele; Agostino Tafuri; Joanna Dulińska-Litewka; Piotr Laidler; Antonio B D'Assoro; Lyudmyla Drobot; Drobot Umezawa; Giuseppe Montalto; Melchiorre Cervello; Zoya N Demidenko
Journal:  Oncotarget       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.